Benazepril hydrochloride
CAS No. 86541-74-4
Benazepril hydrochloride( CGS 14824A )
Catalog No. M16285 CAS No. 86541-74-4
Benazepril, brand name Lotensin, is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenazepril hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenazepril, brand name Lotensin, is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure.
-
DescriptionBenazepril, brand name Lotensin, is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsCGS 14824A
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
RecptorACE
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number86541-74-4
-
Formula Weight460.95
-
Molecular FormulaC24H29ClN2O5
-
Purity>98% (HPLC)
-
SolubilityEthanol: 92 mg/mL (199.58 mM); Water: 19 mg/mL (41.21 mM); DMSO: 92 mg/mL (199.58 mM)
-
SMILESCCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Song JC, White CM. Clin Pharmacokinet. 2002;41(3):207-24.
molnova catalog
related products
-
Fosinopril sodium
Fosinopril Sodium is the ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor.
-
Angiotensin III, hum...
Angiotensin III, human, mouse is a heptapeptide, acts as an endogenous angiotensin type 2 receptor (AT2R) agonist, with IC50s of 0.648 nM and 21.1 nM for AT2R and AT1R, respectively.
-
SSAA09E2
SSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
Cart
sales@molnova.com